Other Non-Current Liabilities
AbbVie Other Non-Current Liabilities increased by 4.7% to $34.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $31.19B to $34.11B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 3.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.80B | $29.10B | $28.70B | $28.02B | $30.77B | $30.22B | $30.66B | $32.25B | $32.29B | $31.64B | $32.33B | $32.78B | $32.43B | $33.03B | $30.13B | $31.19B | $32.04B | $31.66B | $32.57B | $34.11B |
| QoQ Change | — | +1.0% | -1.4% | -2.4% | +9.8% | -1.8% | +1.5% | +5.2% | +0.1% | -2.0% | +2.2% | +1.4% | -1.1% | +1.9% | -8.8% | +3.5% | +2.7% | -1.2% | +2.9% | +4.7% |
| YoY Change | — | — | — | — | +6.8% | +3.8% | +6.8% | +15.1% | +5.0% | +4.7% | +5.5% | +1.6% | +0.4% | +4.4% | -6.8% | -4.8% | -1.2% | -4.2% | +8.1% | +9.4% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is AbbVie's other non-current liabilities?
- AbbVie (ABBV) reported other non-current liabilities of $34.11B in Q1 2026.
- How has AbbVie's other non-current liabilities changed year-over-year?
- AbbVie's other non-current liabilities increased by 9.4% year-over-year, from $31.19B to $34.11B.
- What is the long-term trend for AbbVie's other non-current liabilities?
- Over 5 years (2020 to 2025), AbbVie's other non-current liabilities has grown at a 3.4% compound annual growth rate (CAGR), from $27.61B to $32.57B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.